International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
- Status
- COMPLETED
- Phase
- PHASE3
A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
BG9928 in Subjects With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS
- Status
- COMPLETED
- Phase
- PHASE1
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects
- Status
- COMPLETED
- Phase
- PHASE3
A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function
- Status
- COMPLETED
- Phase
- N/A
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of Repeat Courses of IM Alefacept
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients
- Status
- TERMINATED
- Phase
- PHASE3
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a
- Status
- WITHDRAWN
- Phase
- PHASE4
Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri
- Status
- TERMINATED
- Phase
- PHASE4